These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6224630)

  • 1. Bleeding disorders associated with newer cephalosporins.
    Quintiliani R
    Clin Pharm; 1983; 2(4):360-1. PubMed ID: 6224630
    [No Abstract]   [Full Text] [Related]  

  • 2. Moxalactam-induced coagulopathy.
    Jensen BC
    Clin Pharm; 1983; 2(4):301-2. PubMed ID: 6224629
    [No Abstract]   [Full Text] [Related]  

  • 3. Coagulopathy associated with moxalactam.
    Lee S; Spira S; Gabor EP
    JAMA; 1983 Apr; 249(15):2019-20. PubMed ID: 6220163
    [No Abstract]   [Full Text] [Related]  

  • 4. Bleeding problems.
    Childs SJ
    Arch Intern Med; 1983 Jan; 143(1):183-4. PubMed ID: 6217791
    [No Abstract]   [Full Text] [Related]  

  • 5. Moxalactam and hemorrhage.
    Jones SR; Kimbrough RC
    Ann Intern Med; 1983 Jul; 99(1):126. PubMed ID: 6222681
    [No Abstract]   [Full Text] [Related]  

  • 6. Hemorrhage, diarrhea, and superinfection associated with the use of moxalactam.
    Panwalker AP; Rosenfeld J
    J Infect Dis; 1983 Jan; 147(1):171-2. PubMed ID: 6218209
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse effects of new cephalosporins.
    Jenkinson SG
    Ann Intern Med; 1983 Mar; 98(3):415-6. PubMed ID: 6219604
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolonged bleeding times and bleeding diathesis associated with moxalactam administration.
    Weitekamp MR; Aber RC
    JAMA; 1983 Jan; 249(1):69-71. PubMed ID: 6217353
    [No Abstract]   [Full Text] [Related]  

  • 9. Moxalactam-associated platelet dysfunction.
    Slonaker CE; Luper WE
    JAMA; 1983 Aug; 250(6):729-30. PubMed ID: 6224031
    [No Abstract]   [Full Text] [Related]  

  • 10. Moxalactam, bleeding, and renal insufficiency.
    D'Elia JA; Kaldany A; Miller DG; Yoburn DC; Kaye WA
    JAMA; 1983 Mar; 249(12):1565. PubMed ID: 6219234
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypoprothrombinemic potential of moxalactam.
    Holt RJ
    Clin Pharm; 1982; 1(4):305. PubMed ID: 6224628
    [No Abstract]   [Full Text] [Related]  

  • 12. Enterococcal liver abscess associated with moxalactam therapy. Review of literature on enterococcal superinfections in association with moxalactam therapy.
    Thomas CT; Berk SL; Thomas E
    Arch Intern Med; 1983 Sep; 143(9):1780-1. PubMed ID: 6225403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulopathy associated with the use of moxalactam.
    Pakter RL; Russell TR; Mielke CH; West D
    JAMA; 1982 Sep; 248(9):1100. PubMed ID: 6213792
    [No Abstract]   [Full Text] [Related]  

  • 14. Bleeding secondary to vitamin K deficiency in patients receiving parenteral cephem antibiotics.
    Shimada K; Matsuda T; Inamatsu T; Urayama K
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():325-30. PubMed ID: 6389475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic-associated colitis during moxalactam therapy.
    Tofte RW
    J Antimicrob Chemother; 1981 Apr; 7(4):445-6. PubMed ID: 6454676
    [No Abstract]   [Full Text] [Related]  

  • 16. Interaction between moxalactam and alcohol.
    Neu HC; Prince AS
    Lancet; 1980 Jun; 1(8183):1422. PubMed ID: 6104213
    [No Abstract]   [Full Text] [Related]  

  • 17. Theophylline elixir, moxalactam, and a disulfiram reaction.
    Brown KR; Guglielmo BJ; Pons VG; Jacobs RA
    Ann Intern Med; 1982 Oct; 97(4):621-2. PubMed ID: 6214982
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulopathy associated with the use of cephalosporin or moxalactam antibiotics in acute and chronic renal failure.
    Clark J; Hochman R; Rolla AR; Thomas S; Miller DG; Kaldany A; D'Elia JA
    Clin Exp Dial Apheresis; 1983; 7(3):177-90. PubMed ID: 6671350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe depletion of vitamin-K-dependent clotting factors during postoperative latamoxef therapy.
    MacLennan FM; Ah-See AK; Wong AE; Anderson JA; Bennett B
    Lancet; 1983 May; 1(8335):1215. PubMed ID: 6134006
    [No Abstract]   [Full Text] [Related]  

  • 20. Latamoxef-associated hypoprothrombinaemia.
    Lipsky JJ
    Lancet; 1983 Sep; 2(8350):624. PubMed ID: 6136771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.